Comparison of outcomes after myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplant for chronic myeloid leukemia.
Study #: CK15-02
Study Status: Published
Presentation(s)
2017, ASH (Oral)
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.
Citation
Chhabra S, Ahn KW, Hu Z-H, Jain S, Assal A, Cerny J, Copelan EA, Daly A, DeFilipp Z, Gadalla SM, Gale RP, Ganguly S, Hamilton BK, Hildebrandt GC, Hsu JW, Inamoto Y, Kanate AS, Khoury HJ, Lazarus HM, Litzow MR, Nathan S, Olsson RF, Pawarode A, Ringden O, Rowe JM, Saad A, Savani BN, Schouten HC, Seo S, Shah NN, Solh M, Stuart RK, Ustun C, Woolfrey AE, Yared JA, Alyea EP, Kalaycio ME, Popat U, Sobecks R, Saber W.
Blood Advances. 2018, Nov 13: 2(21): 2(21):2922-2936. doi: 10.1182/bloodadvances.2018024844. Epub 2018, Nov 05. PMCID:PMC6234373.
PubMed
PMID: 30396912
Abstract